- https:
//www.ncbi.nlm.nih.gov/pmc/articles/PMC7393473/ [accessed November 2023] - https:
//www.chop.edu/conditions-diseases/myasthenia-gravis [accessed November 2023] - https:
//www.stanfordchildrens.org/en/topic/default?id=myasthenia-gravis-in-children-90-P02612 [accessed November 2023] - https:
//kidshealth.org/en/parents/myasthenia.html [accessed November 2023] - https:
//www.ncbi.nlm.nih.gov/pmc/articles/PMC3206364/ [accessed November 2023] - https:
//myasthenia.org/Newly-Diagnosed/For-Parents [accessed November 2023]
Juvenile Myasthenia Gravis (JMG)
What is it?
Juvenile Myasthenia Gravis (JMG) is a lifelong condition that usually begins before age 18. It is the most common of the types of MG in children and young people (the other being Transient Neonatal MG), and most commonly affects white teenaged girls.
In JMG, antibodies generated by the immune system – which normally fight off viruses – mistakenly attack muscle nerve receptors, leading to muscle weakness. Medications and treatments are available to help your child tackle their symptoms.
The outlook for younger patients with Juvenile MG is good. With proper treatment and care, your child can lead a full life.
Diagnosis for MG
If you think your child is experiencing symptoms of Juvenile Myasthenia Gravis, here’s how to get a diagnosis for them
Read more
Treatment of MG
What can you do to alleviate the condition, and what treatments are available?
Read more
Living with a child with Juvenile MG
Living with a child with Juvenile MG can mean coping with uncertainty. Learn how to control your child’s symptoms day to day
Read moreIf you are concerned about anything you have read in this article, please seek advice from your healthcare provider.
References
Reporting side effects
You can help by reporting any side effects you may get. By reporting side effects you can help provide more information on the safety of this medicine.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the patient information leaflet. You can also report side effects directly in the UK via the Yellow Card Scheme website: https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card App in the Google Play or Apple App Store. In Ireland please report via the HPRA at https://www.hpra.ie/homepage/about-us/report-an-issue.
You can also report adverse events to UCB at UCBCares.UK@ucb.com or UCBCares.IE@ucb.com